Cushman & Wakefield's healthcare capital markets update for the first half of 2024 is focusing heavily on medical outpatient buildings. The short take: volume and pricing have remained muted, but there was continued resiliency in the category.
Medical outpatient buildings, not to be confused with medical office buildings — both being called MOBs, though this report is about the first type — have become important to the overall healthcare industry. Evolving demographics, changing reimbursement policies, and technology make the decentralization of care delivery desirable and necessary.
There had been a sharp increase in the volume and pricing of medical outpatient buildings between 2020 and 2022, but that has fallen due to inflation, rising interest rates, and a lack of liquidity as many sources wait for someone else to take the risk of the plunge. And yet, the asset class has remained "resilient," according to the CRE firm.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
